Subscribe To
Coherus biosciences launches biosimilar version of abbvie's blockbuster humira
Coherus BioSciences said on Monday it has launched a copycat version of AbbVie's Humira in the United States at a discount of over 85% to the blockbus...
July 3, 2023, 9:12 am
Organon, samsung bioepis launch copycat for arthritis drug humira at 85% discount
Drugmaker partners Organon and Samsung Bioepis said on Saturday that they had launched a far cheaper copycat version of AbbVie's blockbuster ...
July 1, 2023, 8:04 am
Organon, samsung bioepis launch copycat for athritis drug humira at 85% discount
Drugmaker partners Organon and Samsung Bioepis said on Saturday that they had launched a far cheaper copycat version of AbbVie's blockbuster ...
July 1, 2023, 6:38 am
Sandoz launches rival version of abbvie's arthritis drug humira
Swiss drugmaker Sandoz said on Saturday it had launched a biosimilar version of AbbVie Inc's big selling arthr...
July 1, 2023, 12:20 am
For abbvie's blockbuster humira, cheaper competitors pose surprisingly little threat, analysts say
AbbVie's ABBV, +1.53% rheumatoid arthritis drug Humira, one of the top-selling biopharmaceutical produc...
June 30, 2023, 1:28 pm
Nfl alumni health and paradigm anticipate touchdown for unmet osteoarthritis pain
NFL Alumni support ex-NFL players with medical symposium during NFL Draft Mount Laurel, NJ, June 27, 2023 (GLOBE NEWSWIRE) — In tandem with the NFL ...
June 27, 2023, 5:03 pm
Psoriatic arthritis therapeutics market to grow at a cagr of 8.0% from 2022 to 2031, reaching usd 24.2 billion: as per tmr study
Technological advancements in drug delivery system, is another factor that is anticipated to stimulate the psoriatic ...
June 23, 2023, 8:30 pm
Unitedhealth unit to add boehringer's humira biosimilar to reimbursement list
Boehringer Ingelheim's biosimilar of AbbVie Inc's blockbuster arthritis drug Humira will be included in...
June 23, 2023, 12:23 pm
Abbvie, coherus agree to resolve dispute over humira biosimilar
Coherus BioSciences Inc said on Thursday it had agreed to resolve a dispute over its plans to launch a lower-priced version of AbbVie Inc's Humira, it...
June 15, 2023, 7:10 am
Why aclaris therapeutics topped the market on tuesday
The biotech has completed enrollment in the next phase of an important development program. It is aiming to get a rheumatoid ...
June 13, 2023, 6:30 pm
Dr. reddy's (rdy) meets goals in actemra biosimilar study
Dr. Reddy's (RDY) announces meeting primary and secondary endpoints in the phase I study of its proposed tocilizumab biosimilar for the treatment of r...
June 6, 2023, 7:59 am
Coherus biosciences to launch humira biosimilar at $995 per carton
Coherus BioSciences Inc said on Thursday it plans to launch a biosimilar of AbbVie Inc's blockbuster arthritis...
June 1, 2023, 9:24 am
Hip replacement implants market is likely to reach usd 7.0 bn by 2031 growing with cagr of 4.0%: tmr study
Significant rise in adoption of total hip arthroplasty (THA) procedures for end-stage degenerative hip osteoar...
May 11, 2023, 2:30 pm
Galapagos stands strong on jyseleca positive clinical data
Galapagos' focuses on immunology and oncology, with its flagship Jyseleca being used to treat rheumatoid arthr...
May 6, 2023, 1:59 am
Cult food science announces mou with jellatech to create collagen-enhanced pet foods
CULT Food Science Corp (CSE:CULT, OTCQB:CULTF) has announced a partnership with JellaTech, a company producing collagen through cellular agriculture,...
April 11, 2023, 8:03 am
Axial spondyloarthritis management market is expected to reach us$ 7.3 billion, & expected to grow with a 5.1% cagr during 2023 to 2033 | future market insights, inc.
Hospitals Expected to Hold 40% Of Market Share for Axial Spondyloarthritis Management Market. North Ame...
March 31, 2023, 11:30 am
Nurix's stock rallies on gilead's option
Shares of Nurix Therapeutics Inc. NRIX, -0.99% gained about 6% in premarket trading on Monday after Gilead Sciences Inc. GILD, -3.18% said it exercise...
March 20, 2023, 9:00 am
[trending] global rheumatoid arthritis drugs market size & share to hit $ 70.1 billion by 2030 at a 1.75% cagr: growing cases of rheumatoid arthritis to propel market demand- facts & factors
The global rheumatoid arthritis drugs market size was valued at USD 60.1 billion in 2021 and is expecte...
February 10, 2023, 9:10 am
The global orthobiologics market valued at $6 billion (2023), is set to witness a growth rate of 3% in the next 10 years | future market insights, inc.
Orthobiologics Market – Patients Suffering from arthritis and Other Spine Disorders. Rising incidence...
February 9, 2023, 4:30 pm
[latest] global psoriatic arthritis market size/share worth usd 22.23 billion by 2030 at a 11.35% cagr: facts & factors (industrial trends, report, analysis, players, outlook, forecast, growth, value,
The global psoriatic arthritis market size was valued at USD 8.82 billion in 2021 and is expected to su...
February 9, 2023, 10:54 am